Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06915025 |
| Title | Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer (OVATION-3) |
| Acronym | OVATION-3 |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Imunon |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Washington University School of Medicine in St. Louis | RECRUITING | St Louis | Missouri | 63110 | United States | Details |
| Providence Cancer Institute | RECRUITING | Portland | Oregon | 97213 | United States | Details |
| Sanford Health | RECRUITING | Sioux Falls | South Dakota | 57104 | United States | Details |
| Erlanger Health | RECRUITING | Chattanooga | Tennessee | 37403 | United States | Details |
| Providence Sacred Heart Medical Center & Children's Hospital | RECRUITING | Spokane | Washington | 99204 | United States | Details |